Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-043933
Filing Date
2025-03-24
Accepted
2025-03-24 17:00:08
Documents
1
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7819
  Complete submission text file 0000950170-25-043933.txt   9444
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AKARI THERAPEUTICS, PLC 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address
Gaslightwala Abizer (Reporting) CIK: 0002049375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36288 | Film No.: 25764913